NASDAQ
CRISPR Therapeutics AG (CRSP) has a fcf yield of -7.34% as of Friday, May 29, 2026. This represents a 56.78% decrease compared to its 12-month average of -4.68%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.